Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes

Histone deacetylase inhibitors represent a new class of anticancer therapeutics and the expectation is that they will be most effective when used in combination with conventional cancer therapies, such as the anthracycline, doxorubicin. The dose-limiting side effect of doxorubicin is severe cardioto...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Karagiannis, Tom C, Lin, Ann JE, Ververis, Katherine, Chang, Lisa, Tang, Michelle M, Okabe, Jun, El-Osta, Assam
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2010
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2993796/
https://ncbi.nlm.nih.gov/pubmed/20930262
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars